MSN: Who created the polio vaccine?
New generation discovering UC virologist Albert Sabin's work — the polio vaccine
The COVID-19 era is casting light back more than a half century to the time when former University of Cincinnati virologist Albert Sabin developed the live oral polio vaccine. Recent worldwide media coverage, including the latest from MSN, is highlighting the health care hero's work.
"By 1963, Sabin had created an oral live-virus vaccine for all three types of poliovirus that was approved for use by the U.S. government," states the MSN story. "Sabin's version was cheaper and easier to produce than the Salk vaccine, and it quickly supplanted the Salk vaccine in the U.S."
In 1972, Sabin donated his vaccine strains to the World Health Organization (WHO), which greatly increased the vaccine's availability in low-income countries.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Why so much hype around the new Grand Theft Auto?
November 6, 2026
UC experts from DAAP's game and animation program to a doctor at the Lindner Center of HOPE discuss the pros and cons surrounding the upcoming billion-dollar game Grand Theft Auto VI.
Are you experiencing “post-election stress disorder”?
November 6, 2026
Feelings of stress and anxiety tied to election results can persist even after the votes are counted, said University of Cincinnati psychiatrist Julia Stimpfl, MD, even though “post-election stress disorder” is not officially recognized as a mental illness. As she recently told Spectrum News 1 Ohio, those feelings can linger even after an election is finalized.
New UC research identifies biological differences in pancreatic cancer
November 6, 2026
University of Cincinnati Cancer Center research published in Cancer Research found differences in pancreatic cancer tumors and immune environments, opening the possibility for more personalized treatments.